Deceptive Advertising! Claims Novo in GLP-1 Lawsuit Fallout
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Understanding when it's too late to start a retirement plan is crucial for your financial health. This article provides insights to help you assess your situation.
22,641 articlesTwo pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Morgan Stanley labels Microsoft the most under-owned megacap as the stock slides this year. A $50 billion AI investme...
When a stock beats estimates but slides after hours, it creates a nagging question for investors. Here’s a clear, pra...
Copart stock dropped today after the latest earnings report, shaking up portfolios that rely on salvage auctions and ...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
Thirty-five donor families pledged $1.03 billion to multi-year initiatives across the U.S. and beyond, a landmark dis...
As companies report, global grow 2026 earnings becomes a key lens on global demand, margins, and cash flow. This guid...
TeraWulf releases Q4 2025 results after the bell, signaling a shift from Bitcoin mining to AI compute. After-hours tr...
When big funds hold IonQ, retail investors often assume a sure bet. The reality is more nuanced: ownership data refle...
Palantir trades near the $150 level amid volatility. This guide breaks down whether palantir technologies stock no-br...
BTCC reports rapid growth and a broader product slate in 2026, while safety, risk controls, and regulatory compliance...
As Ardent Health closes 2025, the Q4 results shed light on margins, volumes, and balance-sheet health. This analysis ...